EXCLUSIVE: US weighs allowing most pharma licensing deals with China, sources say

Newsylist Editorial Desk. (2026, September 18, 2026). EXCLUSIVE: US weighs allowing most pharma licensing deals with China, sources say: Why it's trending. Newsylist. https://www.newsylist.com/trend/2026-09-18/exclusive-us-weighs-allowing-most-pharma-licensing-deals-with-china-sources-say

@online{newsylist_56873,
  author = {Newsylist Editorial Desk},
  title = {{EXCLUSIVE: US weighs allowing most pharma licensing deals with China, sources say}},
  year = {2026},
  url = {https://www.newsylist.com/trend/2026-09-18/exclusive-us-weighs-allowing-most-pharma-licensing-deals-with-china-sources-say},
  note = {Tracked across 5 independent newsrooms}
}

> According to Newsylist Editorial Desk ([EXCLUSIVE: US weighs allowing most pharma licensing deals with China, sources say](https://www.newsylist.com/trend/2026-09-18/exclusive-us-weighs-allowing-most-pharma-licensing-deals-with-china-sources-say)), this event was corroborated across 5 independent sources with a live velocity of 3.